Variables | MDI | CSII |
---|---|---|
Number of patients | 29 | 29 |
Age (year) | 74.8 ± 12.5 | 74.5 ± 12.3 |
Gender (male: female) | 11:18 | 8:21 |
Hospital stay (days) | 19.83 ± 14.68 | 19.52 ± 11.11 |
Expenses (Yuan) | 15,836.9 ± 6302.6 | 18,139.4 ± 14,163.8 |
FBG (mmol/L) | 10.68 ± 3.47 | 8.54 ± 2.77* |
EPO (mOsm/L) | 298.70 ± 10.87 | 300.87 ± 8.59 |
Na+(mmol/L) | 137.76 ± 3.50 | 139.62 ± 3.37 |
BUN (mmol/L) | 5.99 ± 4.49 | 5.82 ± 3.12 |
Cr (umol/L) | 75.75 ± 34.10 | 73.15 ± 30.57 |
Total number of times that blood glucose monitoring was performed during MDI or CSII therapy | 1523 | 1756 |
Total number of hypoglycemic events during MDI or CSII therapy | 15 | 16 |
Percentage of Severe hypoglycemic events (%) | 26.7 (4/15) | 0 (0/16)* |
Number of subjects experiencing hypoglycemia | 7 | 5 |